The quantification inventory for somatoform syndromes (QUISS): A novel instrument for the assessment of severity

European Archives of Psychiatry and Clinical Neuroscience

Volumn 257, Issue 3, 2007, Pages 153-163

  Wedekind, Dirk ^a   Bandelow, Borwin ^a   Fentzahn, Evelyn ^a   Trümper, Patricia ^a   Rüther, Eckart ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Outcome; Pharmacotherapy; Psychotherapy; Severity scale; Somatoform disorders

Indexed keywords

ADULT; AGED; ARTICLE; COGNITION; CONTROLLED STUDY; CRONBACH ALPHA COEFFICIENT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EXTERNAL VALIDITY; FEMALE; HUMAN; INTERRATER RELIABILITY; MAJOR DEPRESSION; MALE; PANIC; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOTHERAPY; QUANTIFICATION INVENTORY FOR SOMATOFORM SYNDROME; QUESTIONNAIRE; RATING SCALE; SOMATOFORM DISORDER; TEST RETEST RELIABILITY;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGED; ANXIETY; BEHAVIOR; COGNITION; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FACTOR ANALYSIS, STATISTICAL; FEMALE; HEALTH STATUS; HUMANS; HYPOCHONDRIASIS; MALE; MIDDLE AGED; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SELF MEDICATION; SOCIAL BEHAVIOR; SOMATOFORM DISORDERS; TREATMENT OUTCOME;

EID: 34247156339     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-006-0700-4     Document Type: Article

References (29)

1. Altamura AC, Carta MG, Tacchini G, Musazzi A, Pioli MR (1998) Prevalene of somatoform disorders in a psychiatric population. Italian collaborative group on somatoform disorders. Eur Arch Psychiatry Clin Neurosci 248(6):267-271
2. Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK (1993) The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 50:85-94
3. Rief W, Schaefer S, Hiller W, Fichter MM (1992) Lifetime diagnoses in patients with somatoform disorder: which came first? Eur Arch Psychiatry Clin Neurosci 241:236-240
4. Rief W, Hiller W, Geissner E, Fichter MM (1995) A two year follow up study of patients with somatoform disorders. Psychosomatics 36:376-386
5. Swartz M, Blazer D, George L, Landermann R (1986) Somatoform disorders in a community population. Am J Psychiatry 143:1403-1408
6. Bridges KW, Goldberg DP (1985) Somatic presentation of DSM III psychiatric disorders in primary care. J Psychosom Res 29:563-569
7. Zhang M, Booth BM, Smith GR Jr (1998) Service utilization before and after the prospective payment system by patients with somatization disorder. J Behav Health Serv Res 25(1):76-82
8. Zoccolillo M, Cloninger CR (1986) Somatization disorder: psychologic symptoms, social disability, and diagnosis. Compr Psychiatry 27:65-73
9. Hiller W, Fichter MM, Rief W (2003) A controlled treatment study of somatoform disorders including analysis of healthcare utilization and cost-effectiveness. J Psychosom Res 54(4):369-380
10. Stahl SM (2003) Antidepressants and somatic symptoms: therapeutic actions and expanding beyond active spectrum disorders to functional somatic syndromes. J Clin Psychiatry 64(7):745-746
11. Bell IR (1994) Somatization disorder: health care costs in the decade of the brain. Biol Psychiatry 35(2):81-83
12. Fava M (2002) Somatic symptoms, depression, and antidepressant treatment. J Clin Psychiatry 63(4):305-307
13. Kroenke K, Swindle R (2000) Cognitive-behavioural therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 69(4):205-215
14. Hamilton M (1969) The assessment of anxiety by rating. Br J Med Psychol 32:50-55
15. Hathaway SR, Briggs PF (1957) Some normative data on new MMPI scales. J Clin Psychol 13 (4) 364-368
16. Montgomery SA, Åsberg M (1979) A new depression rating scale designed to be sensitive to change. Br J Psychiatry 134:382-389
17. NIMH - National Institute of Mental Health (1970) 12-CGI. Clinical global impressions. In: Guy W (ed) EDCEU assessment in psychopharmacology, rev. ed. Maryland, Rockville, pp. 217-222
18. Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976) The global assessment scale. A procedure for measuring over severity of psychiatric disturbance. Arch Gen Psychiatry 33(6):766-771
19. Hiller W, Rief W (1998) Diagnose und Instrumente In: Margraf J, Neumer S, Rief W (eds) Somatoforme Störungen: Ätiologie, Diagnose und Therapie (ed.). Berlin, Springer-Verlag
20. Hiller W, Janca A (2003) Assessment of somatoform disorders: a review of strategies and instruments. Acta Neuropsychiatrica 15:167-179
21. Rief W, Hiller W (2003) A new approach to the assessment of the treatment effects of somatoform disorders. Psychosomatics 44:492-498
22. APA -American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, Fourth Edition. Washington D.C., American Psychiatric Press
23. WHO (1993) World Health Organisation International classification of mental and behavioural disorders (ICD-10). Clinical descriptions and diagnostic guidelines. Geneva
24. Kroenke K, Spitzer RL, Williams JBW (2002) The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 64:258-266
25. Rief W, Sharpe M (2004) Somatoform disorders - new approaches to classification, conceptualization, and treatment. J Psychosom Res 56:387-390
26. Schmidt FL, Le H, Ilies R (2003) Beyond alpha: an empirical examination of the effects of different sources of measurement error on reliability estimates for measures of individual differences constructs. Psychol Methods 8(2):206-224
27. Pilowsky I (1967) Dimensions of hypochondriasis. Br J Psychiatry 113:89-93
28. Derogatis LR, Cleary PA (1977) Confirmation of the dimensional structure of the SCL-90: A study in construct validation. J Clin Psychol 33:981-989
29. Wittchen HU, Essau CA, von Zerssen D, Krieg JC, Zaudig M (1992) Lifetime and six-month prevalence of mental disorders in the Munich follow-up study. Eur Arch Psychatry Clin Neurosci 241(4):247-258